These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15675125)

  • 21. [Antineutrophil cytoplasmic antibodies (ANCA). Their contribution to the pathogenesis of vasculitis].
    Mirapeix E
    Med Clin (Barc); 1998 Jun; 110(20):778-80. PubMed ID: 9666419
    [No Abstract]   [Full Text] [Related]  

  • 22. Towards diagnostic criteria for the ANCA-associated vasculitides.
    Luqmani RA
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S57. PubMed ID: 17428369
    [No Abstract]   [Full Text] [Related]  

  • 23. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations].
    Holle JU; Lamprecht P
    Z Rheumatol; 2009 Feb; 68(1):75-80. PubMed ID: 19093126
    [No Abstract]   [Full Text] [Related]  

  • 26. Two familial cases of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Rihova Z; Honsova E; Zavada J; Vankova Z; Jancova E; Reiterova J; Tesar V
    Rheumatology (Oxford); 2006 Mar; 45(3):356-7. PubMed ID: 16403828
    [No Abstract]   [Full Text] [Related]  

  • 27. Epigenetics and Vasculitis: a Comprehensive Review.
    Renauer P; Coit P; Sawalha AH
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):357-66. PubMed ID: 26093659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
    Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
    Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenetic aspects of ANCA-associated vasculitides. Editorial overview.
    Csernok E; Trabandt A; Gross WL
    Exp Clin Immunogenet; 1997; 14(3):177-82. PubMed ID: 9493786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis.
    Lesavre P; Kyndt X; Vanhille P; Reumaux D; Guillevin L; Noël LH
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):246-8. PubMed ID: 8946593
    [No Abstract]   [Full Text] [Related]  

  • 31. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
    Holle JU; Gross WL
    J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.
    Clayton AR; Savage CO
    Arthritis Res; 2000; 2(4):260-2. PubMed ID: 11094438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic small vessel vasculitis: pathophysiological aspects of antineutrophil cytoplasm antibodies (ANCA). A review on recent findings.
    Wiik A
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S51-3. PubMed ID: 15309795
    [No Abstract]   [Full Text] [Related]  

  • 36. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis.
    Slot MC; Sokolowska MG; Savelkouls KG; Janssen RG; Damoiseaux JG; Tervaert JW
    Clin Immunol; 2008 Jul; 128(1):39-45. PubMed ID: 18448390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis.
    Esnault VL; Audrain MA; Sesboüé R
    Exp Clin Immunogenet; 1997; 14(3):206-13. PubMed ID: 9493789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.